Bone marrow free immune checkpoints as a potential biomarker for differential diagnosis of acquired bone marrow failures

OBJECTIVE: Clinically, to make a definite diagnosis of aplastic anemia (AA), idiopathic cytopenia of undetermined significance (ICUS) or myelodysplastic syndrome (MDS), they should be distinguished from each other. AA and ICUS have some incidence to transform into MDS. Immunosuppressive therapy (IST...

Descripción completa

Detalles Bibliográficos
Autores principales: Zang, Mengtong, Li, Nianbin, Chen, Qiulin, Ran, NingYuan, Fu, Rong, Shao, Zonghong, Wang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550955/
https://www.ncbi.nlm.nih.gov/pubmed/36086857
http://dx.doi.org/10.1002/jcla.24677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550955/
https://www.ncbi.nlm.nih.gov/pubmed/36086857
http://dx.doi.org/10.1002/jcla.24677

Ejemplares similares